Recently, the U.S. Food and Drug Administration (FDA) has recognized the strong public interest in cannabis and cannabis-derived compounds, particularly CBD.
Many products contain cannabis compounds, including drugs, food, dietary supplements, cosmetics, pet food, and other animal health products.
Researchers from the FDA suggest all customers need to know the products containing cannabis or CBD before using them.
They warn that there may be several health risks from cannabis products:
The effects CBD could cause toxicity to the liver when someone ingests CBD regularly over a long period of time.
One recent study has shown that Epidiolex, a purified form of CBD that the FDA approved in 2018 for use in the treatment of certain seizure disorders, has some safety risks such as liver injury.
It may have harmful effects when they are used far more widely, without medical supervision.
Other than one prescription drug product to treat rare, severe forms of epilepsy, the FDA has not approved any other CBD products.
It has been unknown the effect of the cumulative exposure to CBD if people access it across a broad range of consumer products.
The effects of CBD on special populations (e.g., the elderly, children, adolescents, pregnant and lactating women) or types of animals (including pets) has been unclear, too.
The FDA scientists also warn that some CBD products are being sold with unproven medical claims.
Unapproved CBD drug products have not been subject to FDA review as part of the drug approval process.
There have been no FDA evaluation regarding whether they are safe and effective to treat a particular disease.
So far scientists don’t know what the proper dosage is, how they could interact with other drugs or foods, or whether they have harmful side effects.
For customers, it is important to know that CBD products cannot replace medical care, such as proper diagnosis, treatment, and supportive care.
It is important to talk to doctors about the best way to treat diseases or conditions.
Currently, the FDA is working to evaluate the regulatory frameworks for products containing cannabis and cannabis-derived compounds.
Researchers believe the drug approval process is the best way to help ensure that safe and effective new medicines containing cannabis are available to patients.
Their goal is to update the public with the information they need to make smart choices about CBD products.
Copyright © 2019 Knowridge Science Report. All rights reserved.
